Contents
Is Insulin the Only Option? Exploring Medication Choices for Type 1 Diabetes
Published: Mar 08, 2024
Insulin therapy is a cornerstone of type 1 diabetes treatment, but are there other medication options available? This article explores the role of insulin and other potential therapies.
The Role of Insulin
Insulin is essential for managing type 1 diabetes because it replaces the hormone that the body can't produce. There are various types of insulin, including rapid-acting, long-acting, and intermediate-acting. Each type has a specific role, such as controlling blood sugar spikes after meals or maintaining steady levels throughout the day. Insulin can be delivered through injections or pumps, depending on personal preference and lifestyle.
Exploring Adjunctive Therapies
Some non-insulin medications are being researched for type 1 diabetes, but they aren't widely used yet. Amylin analogs like pramlintide can slow digestion and regulate glucose but may cause gastrointestinal discomfort. Sodium-glucose cotransporter (SGLT) inhibitors help the kidneys expel excess glucose but carry a risk of diabetic ketoacidosis. While these options exist, insulin remains the primary and most effective treatment.
Challenges with Non-Insulin Options
Non-insulin therapies may offer benefits like weight loss or reduced insulin dose but come with risks. The side effects and lack of long-term data make them less favorable. For example, SGLT inhibitors risk causing ketoacidosis, and pramlintide may lead to nausea. Until more research is done, these therapies are not recommended over insulin.
Frequently Asked Questions
There are rapid-acting, long-acting, and intermediate-acting insulins.
Research is ongoing, but insulin remains the main treatment.
Currently, no drugs can replace insulin for type 1 diabetes.
They help kidneys remove excess glucose but have risks.
The Bottom Line
While insulin remains the key treatment, ongoing research may expand future options for managing type 1 diabetes.
References
- Ratner RE, Dickey R, Fineman M, et al. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial. Diabet Med 2004; 21:1204.
- Mathieu C, Zinman B, Hemmingsson JU, et al. Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial. Diabetes Care 2016; 39:1702.
- Henry RR, Thakkar P, Tong C, et al. Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes. Diabetes Care 2015; 38:2258.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?